Admission demographics, site of occlusion, and workflow metrics
| Variables | Total (n = 72 Patients) |
|---|---|
| Age (median) (minimum-maximum) (yr) | 68 (32–89) |
| Men (No.) (%) | 37 (51.4) |
| Stroke on awakening (No.) (%) | 27 (46.6) |
| Site of occlusion (No.) (%) | |
| MCA | 29 (40.3) |
| ACA | 3 (4.0) |
| ICA | 16 (22.2) |
| Tandem | 5 (6.9) |
| Affected hemisphere (No.) (%) | |
| Right | 30 (41.7) |
| Left | 39 (54.2) |
| Coronary artery disease (No.) (%) | 12 (16.7) |
| Congestive heart failure (No.) (%) | 6 (8.3) |
| Valvular disease (No.) (%) | 2 (3.4) |
| Hypertension (No.) (%) | 38 (52.8) |
| Dyslipidemia (No.) (%) | 24 (33.3) |
| Diabetes (No.) (%) | 1 (1.4) |
| Smoking (No.) (%) | 20 (27.8) |
| Statin (No.) (%) | 22 (37.9) |
| EVT treatment (No.) (%) | 72 (100) |
| tPA (alteplase) treatment (No.) (%) | 55 (76) |
| Reperfusion (TICI 2b/3) (No.) (%) | 72 (100) |
| Blood glucose (median) (minimum-maximum) (mmol) | 6 (4.4–20.0) |
| NIHSS baseline (median) (minimum-maximum) | 17 (1–29) |
| NIHSS 24 hours (median) (minimum-maximum) | 6 (0–24) |
| MR spectroscopy baseline (median) (minimum-maximum) | 0 (0–3) |
| MR spectroscopy (median) (minimum-maximum) (90 days) | 2 (0–6) |
| CT to reperfusion time (median) (minimum-maximum) (hh:mm) | 1:28 (0:27–3:06) |
Note:—hh:mm indicates hours: minutes; ACA, anterior cerebral artery.